Vanguard Group
KALA icon

Vanguard Group’s KALA BIO KALA Stock Holding History

Vanguard Group’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$50.6K Sell
1,820
-2,397
-57% -$107K ﹤0.01% 4247
2025
Q3 		$323K Buy
4,217
+809
+24% +$401K ﹤0.01% 4048
2025
Q2 		$811K Buy
3,408
+352
+12% +$68.7K ﹤0.01% 3803
2025
Q1 		$875K Buy
3,056
+1,985
+185% +$751K ﹤0.01% 3753
2024
Q4 		$372K Hold
1,071
– – ﹤0.01% 4007
2024
Q3 		$305K Buy
1,071
+65
+6% +$20.5K ﹤0.01% 4071
2024
Q2 		$357K Buy
1,006
+166
+20% +$54.8K ﹤0.01% 4077
2024
Q1 		$335K Buy
840
+279
+50% +$104K ﹤0.01% 4093
2023
Q4 		$196K Buy
561
+18
+3% +$6.37K ﹤0.01% 4228
2023
Q3 		$241K Hold
543
– – ﹤0.01% 4219
2023
Q2 		$396K Buy
543
+12
+2% +$9.31K ﹤0.01% 4181
2023
Q1 		$399K Buy
531
+327
+160% +$285K ﹤0.01% 4182
2022
Q4 		$389K Sell
204
-271
-57% -$107K ﹤0.01% 4166
2022
Q3 		$263K Sell
475
-104
-18% -$81.7K ﹤0.01% 4376
2022
Q2 		$434K Sell
579
-95
-14% -$149K ﹤0.01% 4322
2022
Q1 		$2.32M Sell
674
-192
-22% -$503K ﹤0.01% 3896
2021
Q4 		$2.62M Sell
866
-41
-5% -$190K ﹤0.01% 3942
2021
Q3 		$5.94M Buy
907
+25
+3% +$216K ﹤0.01% 3542
2021
Q2 		$11.7M Buy
882
+43
+5% +$676K ﹤0.01% 3122
2021
Q1 		$14.1M Buy
839
+65
+8% +$1.27M ﹤0.01% 2965
2020
Q4 		$13.1M Sell
774
-78
-9% -$1.47M ﹤0.01% 2848
2020
Q3 		$16M Sell
852
-30
-3% -$690K ﹤0.01% 2565
2020
Q2 		$23.2M Buy
882
+83
+10% +$2.35M ﹤0.01% 2353
2020
Q1 		$17.5M Buy
799
+363
+83% +$5.8M ﹤0.01% 2360
2019
Q4 		$4.02M Buy
436
+21
+5% +$203K ﹤0.01% 3241
2019
Q3 		$3.94M Sell
415
-81
-16% -$986K ﹤0.01% 3222
2019
Q2 		$7.9M Buy
496
+100
+25% +$1.66M ﹤0.01% 2987
2019
Q1 		$8.18M Sell
396
-10
-2% -$178K ﹤0.01% 2929
2018
Q4 		$4.96M Buy
406
+202
+99% +$3.5M ﹤0.01% 3092
2018
Q3 		$5.04M Buy
204
+15
+8% +$457K ﹤0.01% 3237
2018
Q2 		$6.49M Buy
189
+18
+11% +$691K ﹤0.01% 3110
2018
Q1 		$6.75M Buy
171
+41
+32% +$1.56M ﹤0.01% 3019
2017
Q4 		$5.99M Buy
130
+3
+2% +$140K ﹤0.01% 3058
2017
Q3 		$7.27M Buy
+127
New +$6.97M ﹤0.01% 2963

Other funds holding KALA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Vanguard Group's KALA Position: Q4 2025 in Review

Vanguard Group reduced its KALA BIO (KALA) stake by 57% in Q4 2025, selling an estimated $107K and leaving 1,820 shares worth $50.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4247.

Vanguard Group first reported a position in KALA in Q3 2017 and has held it in 34 quarters since. The position peaked at $23.2M in Q2 2020. 29 funds tracked by Wall St. Rank hold KALA as of Q4 2025.

  • Vanguard Group held 1,820 shares of KALA BIO worth $50.6K as of Q4 2025.
  • Vanguard Group sold 2,397 KALA BIO shares in Q4 2025, an estimated $107K.
  • KALA BIO made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4247 holding.
  • Vanguard Group first reported a position in KALA BIO in Q3 2017 and has held it in 34 quarters since.
  • Vanguard Group's KALA BIO position peaked at $23.2M in Q2 2020.
  • 29 funds tracked by Wall St. Rank held KALA BIO as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.